Quarterly report pursuant to Section 13 or 15(d)

Note 12 - Segment Information (Tables)

v3.20.2
Note 12 - Segment Information (Tables)
3 Months Ended
Sep. 30, 2020
Notes Tables  
Schedule of Segment Reporting Information, by Segment [Table Text Block]
   

Quarter Ended

 
   

September 30,

 
    2020    

2019

 

Net sales:

               

Protein Sciences

  $ 154,446     $ 140,995  

Diagnostics and Genomics

    50,125       42,552  

Intersegment

    (372

)

    (304

)

Consolidated net sales

  $ 204,199     $ 183,243  

Operating income:

               

Protein Sciences

  $ 70,352     $ 59,538  

Diagnostics and Genomics

    8,674       900  

Segment operating income

    79,026       60,438  

Amortization of acquisition related intangible assets

    (15,501

)

    (14,901

)

Acquisition related expenses

    (136

)

    (1,310

)

Stock-based compensation, inclusive of employer taxes

    (13,333

)

    (8,800

)

Corporate general, selling, and administrative expenses

    (964

)

    (2,100

)

Consolidated operating income

  $ 49,092     $ 33,327